过程参数对超临界抗溶剂法共沉淀紫杉醇-PLLA的影响(英文)

Paclitaxel(PTX) is an effective anticancer drug with poor solubility in water.Recently,much effort has been devoted into alternative formulations of PTX for improving its aqueous solubility.In this study,PTX and poly(L-lactic acid)(PLLA) were co-precipitated by a supercritical antisolvent(SAS) process using dichloromethane(DCM) and the mixtures of DCM/ethanol(EtOH) or DCM/dimethyl sulfoxide(DMSO) as the solvent,with super-critical carbon dioxide as the antisolvent.The effects of solvent,solvent ratio,temperature,pressure,polymer con-centration and solution flow rate on particle morphology,mass median diameter(Dp50) and PTX loading were in-vestigated using single-factor method.The particle samples were characterized using X-ray diffraction(XRD),scanning electron microscopy(SEM),laser diffraction particle size analyzer and high pressure liquid chromatogra-phy(HPLC).XRD results indicate that the micronized PTX is dispersed into the PLLA matrix in an amorphous form.SEM indicates that the solvent and the solvent ratio have great effect on the particle morphologies,and particle morphology is good at the volume ratio of DCM/EtOH of 50/50.For the mixed DCM/EtOH solvent,Dp50 increases with the increase of the temperature,pressure,PLLA concentration and solution flow rate,and PTX loading in-creases with pressure.Suitable operating conditions for the experimental system are as follows:DCM/EtOH 50/50(by volume),35 ℃,10-12 MPa,PLLA concentration of 5 g·L-1 and solution flow rate of 0.5 ml·min-1.     

Micronization of the Pharmaceutically Active Agent Genipin by an Antisolvent Precipitation Process

Due to its low water solubility and slow dissolution rate, genipin was micronized by an antisolvent precipitation process using ethanol as solvent and n‐hexane as antisolvent. The effects of various experimental parameters on the mean particle size (MPS) of micronized genipin were investigated. By analysis of variance, only the concentration of the genipin solution has a significant effect on the MPS in genipin micronization. Under the optimum conditions, micronized genipin with an MPS of 1.8 μm was obtained. The micronized genipin was characterized by various methods, e.g., scanning electron microscopy and thermogravimetry. The analysis results indicated that the chemical structure of micronized genipin was not changed, but the crystallinity was reduced. The dissolution rate and solubility of the micronized genipin were 2.08 and 1.64 times that of the raw drug. In addition, the residual amounts of n‐hexane and ethanol were less than the International Conference on Harmonization limit for solvents.     

Recrystallization of erlotinib hydrochloride and fulvestrant using supercritical antisolvent process

Recrystallization of two anti-cancer active pharmaceutical ingredients (APIs), erlotinib hydrochloride (erlotinib HCl) and fulvestrant, using supercritical antisolvent (SAS) process was investigated in this study. The most commonly used supercritical carbon dioxide was employed as the antisolvent. Effect of three process parameters including the operating temperature, pressure and solution flow rate have been studied. Analyses of the recrystallized erlotinib HCl and fulvestrant were examined by SEM, XRD and DSC. Erlotinib HCl was recrystallized from its mean particle size of 20 μm to 2 μm with different crystal habits. Different polymorphs of erlotinib HCl were obtained and confirmed from the XRD and DSC results. The prior art polymorph form A of erlotinib HCl showed enhanced dissolution rate by 3.6 times to its original polymorph form B. Significant particle size reduction was also obtained for fulvestrant. The mean particle size was reduced from its original value of 22 μm to 2 μm with much narrower particle size distribution. The cross-interaction effect between the operating temperature and pressure observed in the SAS treatment of fulvestrant was verified by the method of calculated mixture critical point (MCP). The micronized fulvestrant particles showed consistent polymorph as the original API, but with different crystal habits. It is confirmed that the SAS method is applicable for controlling the crystal properties of two APIs, erlotinib HCl and fulvestrant, which require rigorous control of physical characteristics.     

Micronization of taxifolin by supercritical antisolvent process and evaluation of radical scavenging activity

The aim of this study was to prepare micronized taxifolin powder using the supercritical antisolvent precipitation process to improve the dissolution rate of taxifolin. Ethanol was used as solvent and carbon dioxide was used as an antisolvent. The effects of process parameters, such as temperature (35-65 °C), pressure (10-25 MPa), solution flow rate (3-6 mL/min) and concentration of the liquid solution (5-20 mg/mL) on the precipitate crystals were investigated. With a lower temperature, a stronger pressure and a lower concentration of the liquid solution, the size of crystals decreased. The precipitation temperature, pressure and concentration of taxifolin solution had a significant effect. However, the solution flow rate had a negligible effect. It was concluded that the physicochemical properties and dissolution rate of crystalline taxifolin could be improved by physical modification such as particle size reduction using the supercritical antisolvent (SAS) process. Further, the SAS process was a powerful methodology for improving the physicochemical properties and radical scavenging activity of taxifolin.     

Effect of Voids inside AP Particles on Burning Rate of AP/HTPB Composite Propellant

Bubble contamination in an ammonium perchlorate (AP)‐based composite propellant has a positive effect on the burning rate. However, the quantitative effect of the bubble contamination on the burning rate has never been revealed. In order to clarify the relationship between the increase in the burning rate and the void fraction of the propellant, propellants were prepared with fine porous AP particles (PoAP) or fine hollow AP particles (HoAPs), and their burning rate characteristics were investigated. The voids inside AP particles have the effect of increasing the burning rate. The increase in the burning rate is enhanced linearly as the void fraction increases. The effect of the void fraction on the burning rate for a propellant containing PoAP is not identical with that for a propellant containing HoAP. It was found that the effect of the void fraction on the burning rate could be estimated by the void fraction when the bubble contamination is uniform in size and shape.     

Preparation and characterization of camptothecin powder micronized by a supercritical antisolvent (SAS) process

Micronized camptothecin (CPT) is prepared with a supercritical antisolvent (SAS) apparatus using dimethyl sulfoxide (DMSO) as solvent and carbon dioxide as antisolvent. Four factors, namely CPT solution concentration and flow rate, precipitation temperature and pressure are optimized by a four-level orthogonal array design (OAD). By analysis of variance (ANOVA), only precipitation pressure has a significant effect on the MPS of micronized CPT. The optimum micronization conditions are determined as follows: CPT solution concentration 1.25 mg/ml, CPT solution flow rate 6.6 ml/min, precipitation temperature 35 °C and precipitation pressure 20 MPa. Under the optimum conditions, micronized CPT with a MPS of 0.25 ± 0.020 μm is obtained. The micronized CPT obtained was characterized by Scanning Electron Microscopy (SEM), Atomic Force Microscope (AFM), High performance liquid chromatography-mass spectrometry (LC-MS), Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), Differential scanning calorimeters (DSC) and Gas chromatography (GC) analyses. The results showed that the obtained CPT particles have lower crystallinity and SAS micronization process does not induce degradation of CPT. In addition, the residual DMSO is less than the ICH limit for class 3 solvents.     

反溶剂重结晶法制备青蒿素超细粉体

采用反溶剂重结晶法进行了青蒿素超细粉体的制备研究。以乙醇为溶剂,水为反溶剂,系统考察了药用辅料类型、反溶剂溶剂体积比、药物溶液浓度和混合强度对产品颗粒形貌和大小的影响。结果表明,辅料羟丙甲纤维素(HPMC)与聚乙烯吡咯烷酮 (PVP)联用可有效控制颗粒形貌,反溶剂溶剂体积比为20,青蒿素乙醇溶液浓度为20 mg·ml^-1,搅拌转速为8000 r·min^-1时,浆料中可得到平均短径0.84 μm、长径3 μm的针状颗粒,此浆料经喷雾干燥可得到粒径为2～3 μm的类球形粉体颗粒。进一步采用红外光谱、X射线衍射、差热分析、比表面积测试对原料药及产品的特性进行了表征,结果显示,青蒿素经反溶剂重结晶过程与辅料HPMC间产生一定的氢键作用,超细粉体产品的结晶度及熔点降低,比表面积增至原料药的26.4倍。体外溶出测试结果表明,青蒿素超细粉体的溶出速率远优于原料药,超细药物粉体15 min即可溶出88.3%,而同期原料药的溶出度仅为2.1%。     

Preparation and Characterization of Micronized Artemisinin via a Rapid Expansion of Supercritical Solutions (RESS) Method

The particle sizes of pharmaceutical substances are important for their bioavailability. Bioavailability can be improved by reducing the particle size of the drug. In this study, artemisinin was micronized by the rapid expansion of supercritical solutions (RESS). The particle size of the unprocessed white needle-like artemisinin particles was 30 to 1200 μm. The optimum micronization conditions are determined as follows: extraction temperature of 62 °C, extraction pressure of 25 MPa, precipitation temperature 45 °C and nozzle diameter of 1000 μm. Under the optimum conditions, micronized artemisinin with a (mean particle size) MPS of 550 nm is obtained. By analysis of variance (ANOVA), extraction temperature and pressure have significant effects on the MPS of the micronized artemisinin. The particle size of micronized artemisinin decreased with increasing extraction temperature and pressure. Moreover, the SEM, LC-MS, FTIR, DSC and XRD allowed the comparison between the crystalline initial state and the micronization particles obtained after the RESS process. The results showed that RESS process has not induced degradation of artemisinin and that processed artemisinin particles have lower crystallinity and melting point. The bulk density of artemisinin was determined before and after RESS process and the obtained results showed that it passes from an initial density of 0.554 to 0.128 g·cm(-3) after the processing. The decrease in bulk density of the micronized powder can increase the liquidity of drug particles when they are applied for medicinal preparations. These results suggest micronized powder of artemisinin can be of great potential in drug delivery systems.     

Fabrication and biocompatibility of porously bioactive scaffold of nonstoichiometric apatite and poly(ε‐caprolactone) nanocomposite

Bioactive nanocomposite of nonstoichiometric apatite (ns‐AP) and poly(ε‐caprolactone) (PCL) was synthesized and its porous scaffold was fabricated. The results show that the hydrophilicity and cell attachment ratio on the composite surface improved with the increase of ns‐AP content in PCL. The composite scaffolds with 60 wt % ns‐AP content contained open and interconnected pores ranging in size from 200 to 500 μm and exhibit a porosity of around 80%. In addition, proliferation of MG₆₃ cells on the composite scaffolds significantly increased with the increase of ns‐AP content, and the level of alkaline phosphatase (ALP) activity and nitric oxide (NO) production of the cells cultured on the composite scaffold were higher than that of PCL at 7 days, revealing that the composite scaffolds had excellent in vitro biocompatibility and bioactivity. The composite scaffolds were implanted into rabbit mandible defects, the results suggest that the introduction of ns‐AP into PCL enhanced the efficiency of new bone formation, and the ns‐AP/PCL composite exhibited in vivo good biocompatibility and osteogenesis. © 2009 Wiley Periodicals, Inc. J Appl Polym Sci, 2010     

Liquid Antisolvent Recrystallization of Phenylbutazone and the Effect of Process Parameters

Phenylbutazone was crystallized from solutions by the liquid antisolvent recrystallization technique. Acetone was used as a solvent, and distilled water was selected as an antisolvent. The influence of processing parameters, such as drug concentration, temperature, injection rate of drug solution, and mixing method of drug solution with antisolvent, on the particle size distribution were investigated. Furthermore, to examine the variation of resulting particle size in the presence of the ultrasound, the ultrasonic wave was applied to all experiments. Larger crystals were obtained when crystallization took place at higher temperatures. The enhancement of drug concentration favored decreased particle size. Regarding the mixing method of the drug solution and antisolvent, smaller particles were produced when the drug solution was injected into antisolvent, and larger crystals were obtained when the antisolvent was injected into drug solutions. As the injection rate of the drug solution increased, the average particle size decreased. The processed particles consistently exhibited an acicular crystal habit. The presence of ultrasound caused a reduction of particle size under all operational conditions.     

Crystallization of sulfamethizole using the supercritical and liquid antisolvent processes

Sulfamethizole was crystallized using both the supercritical and liquid antisolvent processes. Acetone and N,N-dimethyl formamide (DMF) were selected as solvents for the pharmaceutical compound, and carbon dioxide and distilled water were used as antisolvents. In the supercritical antisolvent process, the effects of experimental conditions such as carbon dioxide injection rate, type of solvent, and temperature were investigated. In the liquid antisolvent process, the effect of ultrasound on the properties of crystal was examined. The various crystal habits such as tabular, platy, acicular, and prismatic were observed depending on the process and experimental conditions. Differential scanning calorimetry (DSC) measurement revealed that the carbon dioxide injection rate affected the crystallinity of sulfamethizole particles. Larger crystals were obtained at higher temperatures in the two antisolvent processes. The particle size distribution was mostly affected by the antisolvent injection rate and the application of ultrasound.     

Nanoparticle formation of lycopene/β-cyclodextrin inclusion complex using supercritical antisolvent precipitation

With a view to promoting dispersion of lycopene in water, the precipitation of an inclusion complex of lycopene and β-cyclodextrin was investigated using the solution-enhanced dispersion by supercritical fluids (SEDS) process. The inclusion complex, which was prepared in N,N-dimethylformamide (DMF), was dissolved in the same solvent and then micronized by SEDS, using carbon dioxide (CO₂) as a supercritical antisolvent. The effects of the initial concentrations of lycopene and β-cyclodextrin, the CO₂ flow rate, the solution flow rate, and the pressure and temperature at which the process was conducted were examined. The morphologies of the resulting particles were observed by scanning electron microscopy (SEM) and field emission-scanning electron microscopy (FE-SEM). Small spherical particles were obtained at all operating conditions. At high pressure, high temperature, high CO₂ flow rate and low solution flow rate, particles with an average particle size of about 40 nm were obtained.     

Characterization of silver and silver/nickel composite particles prepared by spray pyrolysis

Pure silver and silver/nickel composite particles were prepared by spray pyrolysis of aqueous solutions of AgNO₃, and mixed salts of AgNO₃ and Ni(NO₃)₂·6H₂O, respectively. In the case of pure silver, reduction to metallic silver and subsequent sintering to highly spherical and dense particles took place immediately and almost simultaneously once favorable conditions for the former were imposed, irrespective of the nature of the carrier gas. For the composite particles, the high rates of reduction and sintering of the silver were still maintained, while crystallization of the silver, and the reduction and sintering of the nickel were considerably retarded, compared to the spray pyrolysis of each pure salt. Once the counterpart salt was added, the size of the composite particles increased compared to that of each pure metallic particles, but it was little affected by the furnace set temperature, the residence time and the molar ratio of the two precursor salts. Within single particles, an increase in either the temperature or the residence time caused segregation—silver in the shells and nickel in the cores—and improved the particles' surface smoothness and sphericity accordingly.     

A Novel Preparation Method for Camptothecin (CPT) Loaded Folic Acid Conjugated Dextran Tumor-Targeted Nanoparticles

In this study, folic-dextran-camptothecin (Fa-DEX-CPT) tumor-targeted nanoparticles were produced with a supercritical antisolvent (SAS) technique by using dimethyl sulfoxide (DMSO) as a solvent and carbon dioxide as an antisolvent. A factorial design was used to reveal the effect of various process parameters on the mean particle size (MPS) and morphology of the particles formed. Under the optimum operation conditions, Fa-DEX-CPT nanoparticles with a MPS of 182.21 nm were obtained. Drug encapsulation efficiency and loading efficiency were 62.13% and 36.12%, respectively. It was found that the concentrations of the camptothecin (CPT) and dextran solution had a major influence upon morphology and shape of the final product. In addition, the samples were characterized by Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR), Differential scanning calorimetry (DSC) and X-ray diffraction (XRD) with the purpose of developing a suitable targeted drug delivery system for cancer chemotherapy.     

The influence of operating conditions on the dense gas precipitation of model proteins

Dense gas techniques provide a suite of clean technology options for the processing of pharmaceuticals. Monodisperse, micron‐sized particles can be produced at mild operating temperatures and with negligible solvent residue. In this study, protein was precipitated from organic solutions using dense carbon dioxide as antisolvent. The gas antisolvent precipitation process (GAS) was used to produce biologically active lysozyme, insulin, and myoglobin powders. The effects of operating temperature, solute concentration and the rate of antisolvent addition on the morphology, size, activity and residual solvent concentration of lysozyme and insulin precipitates have been examined. The powders produced consisted of uniformly sized non‐aggregated spherical particles. Precipitate size was controlled between 0.05 µm and 2.0 µm by changes to the solvent and antisolvent compositions. In general the concentration of residual organic solvent was found to be dependent on the mass of antisolvent used during the washing cycle. Residual concentrations as low as 300 ppm were easily achievable in a single step. © 2000 Society of Chemical Industry     

Determination of Solvent Contamination and Characterization of Ultrafine HNS Particles after Solvent Recrystallization

Solvent–antisolvent recrystallization employed for size reduction of HNS has been described and the effect of various parameters such as stirring rate, effect of antisolvent type, antisolvent temperature, ultrasonication, etc. was investigated. Purified HNS, produced by hot solvent recrystallization of production grade crude HNS, of mean particle size ∼95 μm was used for preparation of ultrafine particles of HNS. Solvent contamination in terms of residual solvent was determined by ¹H NMR and GC‐MS analysis. In addition, ultrafine HNS has been characterized for purity (HPLC, ¹H NMR), particle size and shape (PSA and SEM), specific surface area (BET analysis), thermal behavior (TGA, DSC), sensitivity (impact, friction), etc. The results have been compared with C‐HNS. UF‐HNS was >99% pure with mean particle size <1 μm. SEM showed submicrometer size rods like particles of HNS as the final material.     

A computational fluid dynamics study of supercritical antisolvent precipitation: Mixing effects on particle size

Supercritical fluids have been extensively used for particle production of many natural and pharmaceutical substances providing useful alternatives for pharmaceutical and nutraceutical particulate system formulation. Among the different methods, the gas or supercritical antisolvent (GAS or SAS) process and its variants, have received a considerable interest due to the wide range of materials that can be micronized. Controlling particle formation in order to nucleate small particles is a key issue in GAS and SAS processes and this is directly related to mixing at all scales. In this work, we focus on numerical simulation of the process, emphasizing mixing modeling. Different mixing devices characterized by different nozzles are analyzed, to get an insight into mixing dynamics and its influence on the final particle size distribution. Results show that mixing is determinant in obtaining small particles, and that mixing at the microscale is a significant parameter to account for in the proper design of precipitators. © 2011 American Institute of Chemical Engineers AIChE J, 2012     

Formation of biodegradable polymeric fine particles by supercritical antisolvent precipitation process

The supercritical antisolvent (SAS) precipitation process as a “green” alternative to specialty particles recrystallization was successfully used to generate poly(L ‐lactide) acid (L‐PLA) from dichloromethane (DCM) solution using CO₂ as antisolvent. The influence of main operating parameters on the synthesis of L‐PLA particles in the SAS process was methodically examined. In particular, antisolvent addition rate (30, 40, 50, and 60 g/min), temperature (35, 40°C, 45°C, and 50°C), solute concentration (50, 75, 100, and 150 mg/10 ml), and solution addition rate (1, 2.5, 5, and 7.5 ml/min). These parameters could be tuned to give a mean particle diameter of 0.62 μm. It was found using scanning electron microscopy and laser diffraction that increasing the antisolvent addition rate and the solution addition rate, while decreasing the temperature and solute concentration, led to a decrease in the L‐PLA mean particle diameter. Furthermore, a unimodal particle size distribution was obtained at the higher solution and antisolvent addition rates. Spherical‐like primary particles have been obtained in all the experimental runs; thus, no change of particle morphology with the process parameters has been noticed. These results manifested that SAS recrystallization process is a valuable technique to generate reproducibly polymer particles with controlled size and size distribution. POLYM. ENG. SCI. 2013. © 2012 Society of Plastics Engineers     

超临界反溶剂过程制备槲皮素超细颗粒

Supercritical antisolvent (SAS) process is a recently developed technology to produce micro- and nanoparticles. This paper presents a continuous apparatus to conduct experiment of SAS process. With the apparatus,the effects of pressure, temperature and flow ratio of CO2 to the solution on the shape and size of particles are studied for the quercetin-ethanol-CO2 system. Spherical quercetin microparticles with diameters ranging form i μm to 6μm can be obtained while ethanol is used as organic solvent. The most effective fact on the shape and size of particles is pressure, the next is temperature and the last is the flow ratio of CO2 to solution.     

超临界流体技术制各类胡萝卜素纳米颗粒

Based on the solubility in supercritical CO2, two strategies in which CO2 plays different roles are used to make quercetine and astaxanthin particles by supercritical fluid technologies. The experimental results showed that micronized quercetine particles with mean particle size of 1.0-1.5 µm can be made via solution enhanced dis-persion by supercritical fluids (SEDS) process, in which CO2 worked as turbulent anti-solvent; while for astaxan-thin, micronized particles with mean particle size of 0.3-0.8 µm were also made successfully by rapid expansion supercritical solution (RESS) process.